Home › Funds › Almitas Capital LLC › LUNG
Almitas Capital LLC position in LUNG
PULMONX CORP · Health Care
Almitas Capital LLC reported holding 1,064,202 shares of LUNG (PULMONX CORP) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.33% of its reported portfolio and ranking #50 among its reported holdings. Almitas Capital LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Almitas Capital LLC's LUNG position evolved
Almitas Capital LLC first disclosed a stake in LUNG in Q2 2026 at 1,064,202 shares (US$1.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.06M | $1.38M | New |
About LUNG and 13F data
LUNG (PULMONX CORP) is a Health Care company. 6 other funds we track also report a position in LUNG. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Almitas Capital LLC
FAQ
How long has Almitas Capital LLC held LUNG?
Almitas Capital LLC has disclosed LUNG holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Almitas Capital LLC's current position in LUNG?
As of Q2 2026, Almitas Capital LLC holds 1.06M shares of LUNG (PULMONX CORP), valued at $1.38M, representing 0.33% of its reported portfolio and ranking #50.
Has Almitas Capital LLC been buying or selling LUNG?
In the latest 13F filing (Q2 2026), Almitas Capital LLC newly opened its position in LUNG.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.